Betty H Johnson
Overview
Explore the profile of Betty H Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
724
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunkeaw N, Lee Y, Im W, Jang J, Song M, Yang B, et al.
Proc Natl Acad Sci U S A
. 2019 Apr;
116(17):8289-8294.
PMID: 30948645
DNA-reactive compounds are harnessed for cancer chemotherapy. Their genotoxic effects are considered to be the main mechanism for the cytotoxicity to date. Because this mechanism preferentially affects actively proliferating cells,...
2.
Ahn J, Lee H, Lee J, Lee Y, Park J, Kim S, et al.
Nat Commun
. 2018 Dec;
9(1):5458.
PMID: 30568190
In the original version of the Supplementary Information file associated with this Article, Supplementary Fig. 18 panel b was inadvertently replaced with a duplicate of panel a. The error has...
3.
Ahn J, Lee H, Lee J, Lee Y, Park J, Kim S, et al.
Nat Commun
. 2018 Mar;
9(1):1166.
PMID: 29563500
Transforming growth factor-β (TGF-β) signaling and microRNAs (miRNAs) are important gene regulatory components in cancer. Usually in advanced malignant stages, TGF-β signaling is elevated but global miRNA expression is suppressed....
4.
Miller A, Elam W, Johnson B, Khan S, Kumar R, Thompson E
PLoS One
. 2017 Mar;
12(3):e0174183.
PMID: 28301576
Without a glucocorticoid (GC) ligand, the transcription factor glucocorticoid receptor (GR) is largely cytoplasmic, with its GC-binding domain held in high affinity conformation by a cluster of chaperones. Binding a...
5.
Lee E, Hong S, Shin S, Lee H, Lee J, Park E, et al.
Oncotarget
. 2016 Sep;
7(46):75000-75012.
PMID: 27612419
nc886 is a recently identified cellular non-coding RNA and its depletion leads to acute cell death via PKR (Protein Kinase RNA-activated) activation. nc886 expression is increased in some malignancies, but...
6.
Butz A, Gaydos C, Chung S, Johnson B, Huettner S, Trent M
Clin Pediatr (Phila)
. 2016 Aug;
55(12):1107-12.
PMID: 27507807
Unlabelled: Objective To determine the level of nurse case management and outreach required to notify young women with sexually transmitted infection (STI) positive test results after pelvic inflammatory disease (PID)...
7.
Lee H, Lee K, Jang H, Lee G, Park J, Kim S, et al.
Oncotarget
. 2014 Jul;
5(11):3472-81.
PMID: 25004084
nc886 (= vtRNA2-1 or pre-miR-886) is a recently discovered noncoding RNA that is a cellular PKR (Protein Kinase RNA-activated) ligand and repressor. nc886 has been suggested to be a tumor...
8.
Lee K, Park J, Lee K, Richardson L, Johnson B, Lee H, et al.
Oncotarget
. 2014 Jul;
5(11):3944-55.
PMID: 25003254
nc886 is a 101 nucleotide long non-coding RNA that has been designated as a precursor microRNA or a vault RNA based upon it sequence. nc886 has also been suggested to...
9.
Gong B, Lee Y, Lee I, Shelite T, Kunkeaw N, Xu G, et al.
BMC Infect Dis
. 2013 Jun;
13:285.
PMID: 23800282
Background: Microvascular endothelial barrier dysfunction is the central enigma in spotted fever group (SFG) rickettsioses. Angiogenin (ANG) is one of the earliest identified angiogenic factors, of which some are relevant...
10.
Jeon S, Johnson B, Lee Y
Int J Mol Sci
. 2012 Dec;
13(10):13134-9.
PMID: 23202942
nc886 (= pre-miR-886 or vtRNA2-1) is a non-coding RNA that has been recently identified as a natural repressor for the activity of PKR (Protein Kinase R). The suppression of nc886...